Maxim Group Upgrades Titan Pharmaceuticals (TTNP) to Buy
Tweet
Share
E-mailGet Alerts TTNP Hot Sheet
Price: $4.61 --0%
Rating Summary:
0 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 12 | New: 19
Rating Summary:
0 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 12 | New: 19
Join SI Premium – FREE
Maxim Group analyst Jason McCarthy upgraded Titan Pharmaceuticals (NASDAQ: TTNP) from Hold to Buy with a price target of $11.00.
For an analyst ratings summary and ratings history on Titan Pharmaceuticals click here. For more ratings news on Titan Pharmaceuticals click here.
Shares of Titan Pharmaceuticals closed at $4.18 yesterday.
You May Also Be Interested In
- Northland Upgrades Astera Labs (ALAB) to Outperform, 'Right Time, Customers, and Products'
- JPMorgan Upgrades Amber Enterprises India Ltd (AMBER:IN) to Overweight
- New Street Research Upgrades Micron Technology (MU) to Buy
Create E-mail Alert Related Categories
Hot Upgrades, UpgradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
